190 related articles for article (PubMed ID: 24640602)
1. Radiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticles.
Babincová M; Kontrisova K; Durdík S; Bergemann C; Sourivong P
Pharmazie; 2014 Feb; 69(2):128-31. PubMed ID: 24640602
[TBL] [Abstract][Full Text] [Related]
2. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
3. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia.
Babincov M; Altanerov V; Altaner C; Bergemann C; Babinec P
IEEE Trans Nanobioscience; 2008 Mar; 7(1):15-9. PubMed ID: 18334449
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application.
Bergs JW; Franken NA; Haveman J; Geijsen ED; Crezee J; van Bree C
Int J Hyperthermia; 2007 Jun; 23(4):329-41. PubMed ID: 17558732
[TBL] [Abstract][Full Text] [Related]
5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
7. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
Sawa T; Yoshida T; Ishiguro T; Ogawara M; Kawahara M; Yamamoto S; Yokota S; Maeda H; Asamoto H
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer.
Munaweera I; Shi Y; Koneru B; Saez R; Aliev A; Di Pasqua AJ; Balkus KJ
Mol Pharm; 2015 Oct; 12(10):3588-96. PubMed ID: 26325115
[TBL] [Abstract][Full Text] [Related]
9. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
10. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
Caney C; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
[TBL] [Abstract][Full Text] [Related]
11. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study.
Muller M; Chérel M; Dupré PF; Gouard S; Collet M; Classe JM
Eur Surg Res; 2011; 46(3):139-47. PubMed ID: 21372578
[TBL] [Abstract][Full Text] [Related]
13. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
Jones E; Alvarez Secord A; Prosnitz LR; Samulski TV; Oleson JR; Berchuck A; Clarke-Pearson D; Soper J; Dewhirst MW; Vujaskovic Z
Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
[TBL] [Abstract][Full Text] [Related]
14. Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer.
Tang Q; Chen D
Biomed Mater Eng; 2014; 24(1):711-22. PubMed ID: 24211956
[TBL] [Abstract][Full Text] [Related]
15. Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion.
Sakurai H; Hayakawa K; Mitsuhashi N; Tamaki Y; Nakayama Y; Kurosaki H; Nasu S; Ishikawa H; Saitoh JI; Akimoto T; Niibe H
Int J Hyperthermia; 2002; 18(5):472-83. PubMed ID: 12227932
[TBL] [Abstract][Full Text] [Related]
16. Invited commentary.
Vertrees RA; Zwischenberger JB
Ann Thorac Surg; 2004 Nov; 78(5):1772-3. PubMed ID: 15511472
[No Abstract] [Full Text] [Related]
17. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
Eberhardt WE; Gauler TC; Lepechoux C; Stamatis G; Bildat S; Krbek T; Welter S; Grunenwald D; Fischer B; Rodrigo Hde L; Theegarten D; Le Chevalier T; Seeber S; Stuschke M; Poettgen C
Lung Cancer; 2013 Oct; 82(1):83-9. PubMed ID: 23957964
[TBL] [Abstract][Full Text] [Related]
18. [Latest therapeutic strategy for stage IV non-small cell lung cancer].
Kawate N
Nihon Rinsho; 2002 May; 60 Suppl 5():490-3. PubMed ID: 12101720
[No Abstract] [Full Text] [Related]
19. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
Cakir S; Egehan I
Lung Cancer; 2004 Mar; 43(3):309-16. PubMed ID: 15165089
[TBL] [Abstract][Full Text] [Related]
20. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]